Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 10, Issue 12, Pages 1542
Publisher
MDPI AG
Online
2021-12-17
DOI
10.3390/antibiotics10121542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell Transplantation
- (2021) Takuto Takahashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of CYP2C19 Phenotype and Drug-Drug Interactions on Voriconazole Concentration in Pediatric Patients
- (2021) Xueke Tian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Voriconazole Trough Concentrations in Patients with Child–Pugh Class C Cirrhosis: A Prospective Study
- (2021) Yichang Zhao et al. Antibiotics-Basel
- Impact of obesity on voriconazole pharmacokinetics among pediatric hematopoietic cell transplant recipients
- (2020) Takuto Takahashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factors Associated with Voriconazole Concentration in Pediatric Patients
- (2020) Suyeon Kang et al. THERAPEUTIC DRUG MONITORING
- Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
- (2020) Yi‐Chang Zhao et al. CTS-Clinical and Translational Science
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- (2019) Lydia L. Benitez et al. DRUGS
- The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders
- (2019) Magesa Mafuru et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Risk factors associated with insufficient and potentially toxic voriconazole plasma concentrations: an observational study
- (2019) Xiaochen Wei et al. JOURNAL OF CHEMOTHERAPY
- Impact of CYP2C19 genotype and drug interactions on voriconazole plasma concentrations: a spain pharmacogenetic‐pharmacokinetic prospective multicenter study
- (2019) Sara Blanco Dorado et al. PHARMACOTHERAPY
- Pharmacogenetic of voriconazole antifungal agent in pediatric patients
- (2018) Sarah Allegra et al. PHARMACOGENOMICS
- Therapeutic drug monitoring of voriconazole in children: experience from a tertiary care center in China
- (2018) Lin Hu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Individualized Medication of Voriconazole
- (2018) Ken Chen et al. THERAPEUTIC DRUG MONITORING
- Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy
- (2017) Jarrett R. Amsden et al. Expert Opinion on Drug Metabolism & Toxicology
- Dose optimisation of voriconazole with therapeutic drug monitoring in children: a single-centre experience in China
- (2017) Liang Liu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update
- (2017) Thomas Lehrnbecher et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
- (2017) Judith M. Martin et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole
- (2016) Nicolas Hohmann et al. CLINICAL PHARMACOKINETICS
- Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy
- (2016) Rajendra S. Kadam et al. CLINICAL PHARMACOKINETICS
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre
- (2016) Alison Boast et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition
- (2016) Guo Yu et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
- (2016) Frederic Tissot et al. HAEMATOLOGICA
- Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
- (2014) Andreas H Groll et al. LANCET ONCOLOGY
- Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes
- (2014) J Kevin Hicks et al. PHARMACOGENOMICS
- Steady-state pharmacokinetics and metabolism of voriconazole in patients
- (2013) M. J. P. Geist et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Highly Variable Plasma Concentrations of Voriconazole in Pediatric Hematopoietic Stem Cell Transplantation Patients
- (2012) Imke H. Bartelink et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and Adults
- (2012) Lena E. Friberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Voriconazole in Adults
- (2011) William W. Hope ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients
- (2010) C. Michael et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children
- (2010) T. J. Walsh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
- (2008) M. O. Karlsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic polymorphism analysis ofCYP2C19in Chinese Han populations from different geographic areas of mainland China
- (2008) Lingling Chen et al. PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started